Shares of Teladoc Health Inc (NYSE:TDOC) gapped down before the market opened on Thursday after an insider sold shares in the company. The stock had previously closed at $63.06, but opened at $59.81. Teladoc Health shares last traded at $55.81, with a volume of 4132311 shares changing hands.

Specifically, insider Lewis Levy sold 1,284 shares of the company’s stock in a transaction dated Monday, September 17th. The shares were sold at an average price of $77.00, for a total value of $98,868.00. Following the sale, the insider now owns 1,284 shares in the company, valued at $98,868. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, VP Mark Hirschhorn sold 35,000 shares of the company’s stock in a transaction dated Tuesday, September 25th. The stock was sold at an average price of $80.42, for a total transaction of $2,814,700.00. Following the completion of the sale, the vice president now owns 10,000 shares in the company, valued at approximately $804,200. The disclosure for this sale can be found here. In the last 90 days, insiders sold 245,929 shares of company stock worth $17,034,023. Corporate insiders own 3.95% of the company’s stock.

Several brokerages have recently issued reports on TDOC. KeyCorp upped their target price on shares of Teladoc Health from $74.00 to $90.00 and gave the stock an “overweight” rating in a research note on Monday, August 27th. MED upped their target price on shares of Teladoc Health from $68.00 to $89.00 and gave the stock an “outperform” rating in a research note on Friday, September 28th. Citigroup upped their target price on shares of Teladoc Health from $80.00 to $88.00 and gave the stock a “buy” rating in a research note on Friday, September 21st. Jefferies Financial Group set a $90.00 target price on shares of Teladoc Health and gave the stock a “buy” rating in a research note on Friday, September 28th. Finally, Craig Hallum upped their target price on shares of Teladoc Health from $70.00 to $80.00 and gave the stock a “buy” rating in a research note on Monday, October 15th. Four research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the company’s stock. Teladoc Health currently has a consensus rating of “Buy” and an average target price of $85.06.

The stock has a market cap of $4.19 billion, a price-to-earnings ratio of -33.82 and a beta of 0.92. The company has a current ratio of 8.99, a quick ratio of 8.99 and a debt-to-equity ratio of 0.40.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings data on Thursday, November 1st. The health services provider reported ($0.34) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.36) by $0.02. The company had revenue of $111.00 million for the quarter, compared to the consensus estimate of $109.94 million. Teladoc Health had a negative net margin of 31.32% and a negative return on equity of 14.05%. The firm’s revenue for the quarter was up 61.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned ($0.55) earnings per share. On average, equities analysts forecast that Teladoc Health Inc will post -1.47 earnings per share for the current fiscal year.

A number of institutional investors have recently modified their holdings of the stock. Reynders McVeigh Capital Management LLC lifted its position in Teladoc Health by 2.8% during the third quarter. Reynders McVeigh Capital Management LLC now owns 145,529 shares of the health services provider’s stock valued at $12,566,000 after purchasing an additional 3,930 shares during the period. Diversified Trust Co bought a new position in Teladoc Health during the third quarter valued at approximately $237,000. Vanguard Group Inc. lifted its position in Teladoc Health by 26.9% during the third quarter. Vanguard Group Inc. now owns 5,874,182 shares of the health services provider’s stock valued at $507,236,000 after purchasing an additional 1,244,388 shares during the period. Legal & General Group Plc lifted its position in Teladoc Health by 13.5% during the third quarter. Legal & General Group Plc now owns 24,669 shares of the health services provider’s stock valued at $2,131,000 after purchasing an additional 2,943 shares during the period. Finally, Rehmann Capital Advisory Group lifted its position in Teladoc Health by 8,323.7% during the third quarter. Rehmann Capital Advisory Group now owns 34,453 shares of the health services provider’s stock valued at $399,000 after purchasing an additional 34,044 shares during the period.

TRADEMARK VIOLATION NOTICE: “Teladoc Health (TDOC) Shares Gap Down on Insider Selling” was first published by Watch List News and is the sole property of of Watch List News. If you are reading this piece of content on another domain, it was illegally copied and reposted in violation of U.S. and international copyright & trademark legislation. The correct version of this piece of content can be viewed at https://www.watchlistnews.com/teladoc-health-tdoc-shares-gap-down-on-insider-selling/2665705.html.

Teladoc Health Company Profile (NYSE:TDOC)

Teladoc Health, Inc provides telehealth services worldwide. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.

Recommended Story: Balanced Fund

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.